This detects tumor signal at lower ctDNA levels while reducing interference from clonal hematopoiesis.
Guardant Infinity is for Research Use Only. Not for use in diagnostic procedures
InfinityAI is not a standalone customer product. “Powered by InfinityAI” refers to Guardant Health artificial intelligence and machine learning technology used in development of product features. These features are reported as professional service and have not been cleared or approved by the US FDA.
Methylation-based detection identifies and quantifies tumor signals in late-stage cancers with as low as 0.001% circulating tumor fraction (TF).¹
Home Guardant Infinity™ for BioPharma Guardant360® CDx for BioPharma InfinityAI for BioPharma
QUANTIFY CANCER